No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹104Prev. Close
₹101.67Turnover(Lac.)
₹5.92Day's High
₹104Day's Low
₹98.5152 Week's High
₹18252 Week's Low
₹81.01Book Value
₹90.4Face Value
₹10Mkt Cap (₹ Cr.)
122.86P/E
12.92EPS
7.87Divi. Yield
029 Aug 2025
12:00 AM
AGM
Announcement Date: 29 Aug, 2025
31 Jan 2026
12:00 AM
Board Meeting
Agenda : Audited Result
20 Jan 2025
12:00 AM
EGM
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 12.3 | 12.3 | 12.3 | 12.3 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 86.67 | 73.33 | 58.93 | 47.57 |
Net Worth | 98.97 | 85.63 | 71.23 | 59.87 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|
Revenue | 60.75 | 55.84 | 48.76 |
yoy growth (%) | 8.77 | 14.52 | |
Raw materials | -21.87 | -23.65 | -21.06 |
As % of sales | 36.01 | 42.35 | 43.2 |
Employee costs | -3.97 | -4.11 | -3.18 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|
Profit before tax | 12.74 | 5.99 | 3.26 |
Depreciation | -2.81 | -2.76 | -2.81 |
Tax paid | -3.11 | -1.22 | -1.51 |
Working capital | 14.37 | 10.27 | |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|
Growth matrix (%) | |||
Revenue growth | 8.77 | 14.52 | |
Op profit growth | 69.47 | 10.59 | |
EBIT growth | 97.21 | 17.67 | |
Net profit growth | 143.67 | 171.62 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,711.1 | 94.04 | 4,10,442.24 | 705.44 | 0.94 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,386.5 | 68.37 | 1,71,877.63 | 598 | 0.46 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,056.7 | 64.33 | 1,37,300.55 | 597 | 0.15 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,349.9 | 23.8 | 1,09,030.2 | 616.88 | 1.19 | 4,256.93 | 411.55 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.3 | 22.85 | 1,06,023.09 | 90.6 | 0.63 | 4,266.4 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / M D / Promoter
FALGUN VALLABHBHAI SAVANI
Executive Director & CEO
JIGNESHBHAI VALLABHBHAI SAVANI
Independent Non Exe. Director
Krishna Mitulbhai Shah
Independent Non Exe. Director
Kajal Chintanbhai Vaghani
Independent Non Exe. Director
Pravin Manjibhai Bhayani
Independent Non Exe. Director
Bintal Bhaveshkumar Shah
Company Sec. & Compli. Officer
Sanket Bhupendrabhai Trivedi
805 Dwarkesh Complex,
RC Dutt Road Alkapuri,
Gujarat - 390007
Tel: 91-265-2332018
Website: http://www.pardrugs.com
Email: cs.sanket@pardrugs.com
5th Floor 506 to 508,
ABC-I Off C G Road, Navrangpura,
Ahmedabad-380009
Tel: 91-79-26465179
Website: https://in.mpms.mufg.com/
Email: ipo.team@linkintime.co.in
Summary
Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name Par Drugs and Chemicals Private Limited at Bhavnagar, Gujarat on 26 February 1999. Subsequently, ...
Read More
Reports by Par Drugs & Chemicals Ltd
What is the Par Drugs & Chemicals Ltd share price today?
What is the Market Cap of Par Drugs & Chemicals Ltd?
What is the PE and PB ratio of Par Drugs & Chemicals Ltd?
What is the 52 Week High and Low of Par Drugs & Chemicals Ltd?
What is the CAGR of Par Drugs & Chemicals Ltd?
What is the shareholding pattern of Par Drugs & Chemicals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
